Target intelligence / Profile preview

RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 2 (RRN3P2)

Target
RRN3P2
Molecular classification
Other (Pseudogene)
01

Overview

RRN3P2 is a pseudogene in humans, classified as a putative homolog of the yeast RNA polymerase I transcription factor RRN3 (sometimes also called TIF-1A in yeast). While it is predicted to encode a protein with RNA polymerase I core binding activity and potentially capable of functioning as a general transcription initiation factor for RNA polymerase I, there is no experimental evidence supporting that RRN3P2 produces a functional protein in humans. The gene is inactive and believed to play no direct functional role as a canonical protein or therapeutic target. RRN3P2 is primarily considered a non-coding relic closely related to the functional RRN3 gene, which is involved in ribosomal RNA synthesis and RNA polymerase I transcription, but RRN3P2 itself is not recognized as a drug target and has no established biological, pharmacological, or disease relevance beyond limited bioinformatic association studies[1][2][6][8][12].

Other names
RRN3 pseudogene 2Putative RRN3-like protein RRN3P2RRN3P2RNA polymerase I transcription factor homolog pseudogene 2RRN3 RNA polymerase I transcription factor homolog pseudogeneRRN3 homologRNA polymerase I transcription factor pseudogene 2RRN3-like protein 1RUNDC2CRUN domain containing 2CSNX29P2
02

Disease associations

Other (Not established as disease-associated; predicted association with Atrial Fibrillation annotated, but unclear if causative)

Beyond the preview

Go deeper on RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 2 (RRN3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 2 (RRN3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call